QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SynthesisChina Warehouse
What is Finasteride?
Finasteride is a competitive 5α-reductase Type II inhibitor — reduces testosterone-to-DHT conversion by ~70%. Research tool for androgenetic alopecia, BPH, DHT-mediated tissue biology, and T vs DHT pharmacology. Large-scale powder for high-throughput 5α-reductase inhibition research and formulation development. Research use only.
Research Applications
5α-Reductase Inhibition
Type II isoform competitive inhibition — T→DHT conversion block, Ki determination
DHT-Mediated Biology
Prostate stromal-epithelial signalling, hair follicle DHT sensitivity, skin
BPH Research
Prostatic DHT reduction, stromal volume, inflammatory pathway modulation
Androgenetic Alopecia
Scalp DHT reduction, follicle miniaturisation reversal, dermal papilla research
HPG Axis at Low DHT
Finasteride impact on hypothalamic negative feedback, LH/FSH dynamics
Quick Specs
| Form | Raw bulk powder (crystalline/amorphous) |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | 98319-26-7 |
| Molecular Formula | C₂₃H₃₆N₂O₂, MW 372.5 |
| Identity | MS molecular weight confirmed — every batch |
| Compound Type | 5α-Reductase Type II Inhibitor |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage |
| Shelf Life | 24 months (unopened) |

